Literature DB >> 1666311

The DNA sequence of the human cytomegalovirus genome.

A T Bankier1, S Beck, R Bohni, C M Brown, R Cerny, M S Chee, C A Hutchison, T Kouzarides, J A Martignetti, E Preddie.   

Abstract

In the first part of this article we review what has been learnt from the analysis of the sequence of HCMV. A summary of this information is presented in the form of an updated map of the viral genome. HCMV is representative of a major lineage of herpesviruses distinct from previously sequenced members of this viral family and demonstrates striking differences in genetic content and organization. The virus encodes approximately 200 genes, including nine gene families, a large number of glycoprotein genes, and homologues of the human HLA class I and G protein-coupled receptor genes. The HCMV sequence thus provides a sound basis for future molecular studies of this highly complex eukaryotic virus. The second part discusses the practical rate of DNA sequencing as deduced from this and other studies. The 229 kilobase pair DNA genome of human cytomegalovirus (HCMV) strain AD169 is the largest contiguous sequence determined to date, and as such provides a realistic benchmark for assessing the practical rate of DNA sequencing as opposed to theoretical calculations which are usually much greater. The sequence was determined manually and we assess the impact of new developments in DNA sequencing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666311     DOI: 10.3109/10425179109008433

Source DB:  PubMed          Journal:  DNA Seq        ISSN: 1026-7913


  26 in total

1.  Herpes simplex virus type 1 U(L)34 gene product is required for viral envelopment.

Authors:  R J Roller; Y Zhou; R Schnetzer; J Ferguson; D DeSalvo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation.

Authors:  U Machida; M Kami; T Fukui; Y Kazuyama; M Kinoshita; Y Tanaka; Y Kanda; S Ogawa; H Honda; S Chiba; K Mitani; Y Muto; K Osumi; S Kimura; H Hirai
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Reevaluation of human cytomegalovirus coding potential.

Authors:  Eain Murphy; Isidore Rigoutsos; Tetsuo Shibuya; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

Review 4.  Human cytomegalovirus entry into cells.

Authors:  Adam L Vanarsdall; David C Johnson
Journal:  Curr Opin Virol       Date:  2012-01-30       Impact factor: 7.090

5.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

6.  Spliced transcripts of human cytomegalovirus.

Authors:  W D Rawlinson; B G Barrell
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

Authors:  R D Schrier; W R Freeman; C A Wiley; J A McCutchan
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.

Authors:  W Y Barrett-Muir; C Aitken; K Templeton; M Raftery; S M Kelsey; J Breuer
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Capsid structure of simian cytomegalovirus from cryoelectron microscopy: evidence for tegument attachment sites.

Authors:  B L Trus; W Gibson; N Cheng; A C Steven
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Regulated expression of a Sindbis virus replicon by herpesvirus promoters.

Authors:  L Ivanova; S Schlesinger; P D Olivo
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.